Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia

PHASE3CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Meningococcal Disease
Interventions
BIOLOGICAL

MenACWY-CRM

1 vaccination at visit 1, conjugate vaccine, Intramuscular (IM) injection

Trial Locations (4)

115478

Federal State Budgetary Institution 'State Scientific Center 'Institution of Immunology' of the Russian Federal Biomedical Agency', Kashirskoye Highway

119991

"Institution of the Russian Academy of Sciences Scientific Center for Children Health RAMS", Lomonosovskiy Avenue

197022

Federal State Institution 'Scientific-Research Institution of Children's Infections of the Russian Federal Biomedical Agency', Prof.Popova Street

197101

Federal Budgetary Institution of Science 'St-Petersburg Scientific-Research Institution of Epidemiology and Microbiology by name of Pasteur', Mira Street

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY